medigraphic.com
ISSN 1028-4818 (Electronic)

2021, Number 3

<< Back Next >>

Mul Med 2021; 25 (3)

Influencing factors in death due to pulmonary embolism

Pérez DJA, Ortega VYR, Leblanch PL, Medel AO, Rodríguez PMM

Language: Spanish
References: 22
Page:
PDF size: 499.58 Kb.


ABSTRACT

Introduction: pulmonary thromboembolism (PE) is the most serious consequence of a primary event. It requires a high rate of clinical probability analysis based on the evaluation of the risk factors present.
Objective: to identify prognostic factors for death in patients with pulmonary embolism.
Methods: an analytical study of cases and controls was carried out with 78 patients with PE (26 cases and 52 controls).
Results: mean age 57.3 years, non-significant predominance in the female sex of 53.7% p> 0.05 and in the age group ≤60 years 55.1%, p˃0.05. The fatality was 30.5% without gender predominance. Diabetes mellitus, metabolic syndrome and deep vein thrombosis showed a significant association with death. The logistic regression model showed that pulmonary hypertension adjusted OR 7.1 95% CI (2.5- 9.2) p = 0.01 and right ventricular dysfunction adjusted OR 5.5 95% CI (2.0-8, 6) p = 0.00 showed an independent relationship with the probability of dying.
Conclusions: right ventricular dysfunction and pulmonary hypertension were identified as prognostic factors for death due to PE. The proven results allow us to stratify the patient, constituting a solid base for further predictive studies.


REFERENCES

  1. Ubaldini J. Consenso de Enfermedad Tromboembólica Aguda. Rev Argent Cardiol2016; 84:74-91.

  2. Campanini CA, Zulaica R, de la Noval R, Vásquez D, Calero Carvajal C, García L, et al. Tromboembolismo pulmonar. Sociedad Interamericana de Cardiología. [Internet] 2016. [Consulta 29/12/2019]. Disponible en: http://www.siacardio.com/editoriales/insificiencia-cardiaca/tromboembolismo-pulmonar/.

  3. Servicio de Salud del Principado de Asturias. Recomendaciones para el diagnóstico y el tratamiento de la enfermedad tromboembólica venosa. Diagnóstico y tratamiento de la enfermedad tromboembólica venosa. [Internet]Asturia: Universitario Central de Asturias; 2018.[citado 3/1/2021]. Disponible en: http://www.hca.es/huca/web/documentos/PO_ETEV_Diagn%C3%B3stico_tratamiento_20180315_Ed_1.pdf.

  4. Flores LA, Ubaldini J, Kenar MR, Bilbao J, Bonorino J, Ceresetto J, et al. Guías de manejo y tratamiento de la enfermedad tromboembólica aguda. RATI 2019; 36(2):56-70.

  5. Díaz Patiño O, Andresen Hernández M. Embolia pulmonar: Fisiopatología y diagnóstico. Boletín de la escuela de medicina. [Internet]. 1998 [citado 2/6/2021]; 28(3). Disponible en: https://arsmedica.cl/index.php/MED/article/view/1221/1059.

  6. Lucena RJ, Laborda Gálvez JL, Rodríguez GL. Tromboembolismo pulmonar como causa de muerte súbita inesperada en personas de 1-35 años. Cor Salud 2017; 9(3):215-17.

  7. Acosta Reynoso IM, Zayas Peña YA, Rodríguez Rojas Z, Manso López AM, Santiesteban Guerrero E. Análisis clínico anatomopatológico de pacientes fallecidos con tromboembolismo pulmonar. CCM 2014; 18(4):636-48.

  8. Moore AJE, Wachsmann J, Chamarthy MR, Panjikaran L, Tanabe Y, Rajiah P. Imaging of acute pulmonary embolism: anupdate. Cardiovasc Diagn Ther 2018;8(3):225-43.

  9. Machado Villarroel L, Dimakis Ramírez DA. Enfoque diagnóstico de la tromboembolia pulmonar. Acta méd. Grupo Ángeles2017; 15(1): 6-46.

  10. Alfonso Figueredo E, Pérez Álvarez ML, Reyes Sanamé FA, Batista Acosta Y, Peña Garcell Y. Nuevas consideraciones en el tratamiento del tromboembolismo pulmonar. Rev Cubana Med 2016; 55(3): 224-38.

  11. Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999; 353(9162):1386-9.

  12. Gupta R, Fortman DD, Morgenstern DR, Cooper CJ. Short- and Long-term Mortality Risk After Acute Pulmonary Embolism. Curr Cardiol Rep 2018; 20(12):135-8.

  13. Konstantinides SV, Barco S. Prevention of early complications and late consequences after acute pulmonary embolism: focus on reperfusion techniques. Thromb Res 2018; 164:163-9.

  14. Zhan ZQ, Wang CQ, Nikus KC, He CR, Wang J, Mao S, et al. Electrocardiogram patterns during hemodynamic instability in patients with acute pulmonary embolism. Ann Noninvasive Electrocardiol 2014; 19(6):543-51.

  15. Cronin P, Dwamena BA. A Clinically Meaningful Interpretation of the Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED) II and III Data. Acad Radiol 2018;25(5):561-72.

  16. Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing GJ, Harjola VP, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J 2020; 41(4):543-603.

  17. Coppens M. Management of submassive pulmonary embolism. Neth J Crit Care 2017; 25(5):156-8.

  18. Aujesky D, Roy PM, Le Manach CP, Verschuren F, Meyer G, Obrosky DS, et al. Validation of a model to predict adverse outcomes in patients with pulmonary embolism. Eur Heart J 2006; 27:476-81.

  19. Laínez Ramos-Bosini AJ, Gálvez López R, Moreno Suarez S, Rivera Izquierdo M. Aplicación de la escala de WELLS ante tromboembolismo pulmonar agudo en el servicio de urgencias. Resultados preliminares de un estudio observacional. Actual Med 2018; 103(805):130-5.

  20. Jiménez D, Aujesky D, Moores L, Gómez V, Lobo JL, Uresandi F, et al. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med 2010; 170(15):1383-9.

  21. Stein PD, Matta F. Thrombolytic therapy in unstable patients with acute pulmonary embolism: saves lives but underused. Am J Med 2012; 125(5):465-70.

  22. Shafiq Q, Moukarbel GV, Gupta R, Hernandez DA, Khouri SJ. Practical echocardiographic approach for risk stratification of patients with acute pulmonary embolism. J Echocardiogr 2016; 14(4):146-55.




2020     |     www.medigraphic.com